Literature DB >> 24246330

Cystinuria: current diagnosis and management.

Panagiotis Saravakos1, Vasiliki Kokkinou2, Evangelos Giannatos2.   

Abstract

Cystinuria is an inherited disorder of the dibasic amino acid transport system in the proximal tubule and the small intestine. Two responsible genes have been identified, the SLC3A1 on chromosome 2 and the SLC7A9 on chromosome 19. The inability of renal tubules to reabsorb cystine and the relative insolubility of cystine at physiological urine pH lead to stone formation. Cornerstone of the treatment remains stone prevention with hyperhydration, urinary alkalization, and pharmacologic therapy. Repeated stone formation necessitates urologic interventions, which mainly include minimally invasive procedures. The appropriate management of cystinuria is often challenging and requires close follow-up of the patient.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24246330     DOI: 10.1016/j.urology.2013.10.013

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  20 in total

Review 1.  Cystinuria: genetic aspects, mouse models, and a new approach to therapy.

Authors:  Amrik Sahota; Jay A Tischfield; David S Goldfarb; Michael D Ward; Longqin Hu
Journal:  Urolithiasis       Date:  2018-12-04       Impact factor: 3.436

Review 2.  Diagnosis and management of non-calcium-containing stones in the pediatric population.

Authors:  Saritha Ranabothu; Ari P Bernstein; Beth A Drzewiecki
Journal:  Int Urol Nephrol       Date:  2018-05-30       Impact factor: 2.370

Review 3.  Tubular and genetic disorders associated with kidney stones.

Authors:  Nilufar Mohebbi; Pietro Manuel Ferraro; Giovanni Gambaro; Robert Unwin
Journal:  Urolithiasis       Date:  2016-11-28       Impact factor: 3.436

4.  Design, synthesis, and evaluation of l-cystine diamides as l-cystine crystallization inhibitors for cystinuria.

Authors:  Yanhui Yang; Haifa Albanyan; Sumi Lee; Herve Aloysius; Jian-Jie Liang; Vladyslav Kholodovych; Amrik Sahota; Longqin Hu
Journal:  Bioorg Med Chem Lett       Date:  2018-03-10       Impact factor: 2.823

5.  Protective effect of salvianolic acid B against oxidative injury associated with cystine stone formation.

Authors:  Zhang Yifan; Xu Luwei; Liang Kai; Zhou Liuhua; Ge Yuzheng; Jia Ruipeng
Journal:  Urolithiasis       Date:  2019-02-18       Impact factor: 3.436

6.  Mutation analysis of SLC3A1 and SLC7A9 genes in patients with cystinuria.

Authors:  Leila Koulivand; Mehrdad Mohammadi; Behrouz Ezatpour; Rasoul Salehi; Samane Markazi; Sepideh Dashti; Majid Kheirollahi
Journal:  Urolithiasis       Date:  2015-06-30       Impact factor: 3.436

7.  Multimodal treatments of cystine stones: an observational, retrospective single-center analysis of 14 cases.

Authors:  Myungsun Shim; Hyung Keun Park
Journal:  Korean J Urol       Date:  2014-08-08

Review 8.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

9.  Metabolic disturbances in Chinese children with urolithiasis: a single center report.

Authors:  Dong Yang; Hans-Göran Tiselius; Chuangxin Lan; Dong Chen; Kang Chen; Lili Ou; Yang Liu; Shaohong Xu; Guohua Zeng; Ming Lei; Wenqi Wu
Journal:  Urolithiasis       Date:  2016-08-10       Impact factor: 3.436

10.  Mass Spectrometry-based in vitro Assay to Identify Drugs that Influence Cystine Solubility.

Authors:  Neelanjan Bose; Tiffany Zee; Pankaj Kapahi; Marshall L Stoller
Journal:  Bio Protoc       Date:  2017-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.